Author:
Sindermann J. R.,Scherer M.,Hoffmeier A.,Meyer A. L.,Fischer J.,Garbade J.,Litmathe J.,Pilarczyk K.,Färber G.,Schmid C.
Publisher
Springer Berlin Heidelberg
Reference137 articles.
1. Adamson RM, Dembitsky WP, Baradarian S, Chammas J, May-Newman K, et al. (2011) Aortic valve closure associated with HeartMate left ventricular device support: technical considerations and long-term results. J Heart Lung Transplant 30: 576–582
2. Amir O, Bracey AW, Smart FW, Delgado RM 3rd, Shah N, Kar B (2005) A successful anticoagulation protocol for the first HeartMate II implantation in the United States. Tex Heart Inst J 32: 399–401
3. Argenziano M, Choudhri AF, Moazami N, Rose EA, Smith CR, et al. (1998) Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg 65: 340–345
4. Atz AM, Lefler AK, Fairbrother DL, Uber WE, Bradley SM (2002) Sildenaphil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. J Thorac Cardiovasc Surg 124: 628–629
5. Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, et al. (2011) Right heart failure and „failure to thrive“ after left ventricular assist device: clinical predictors and outcomes. J Heart Lung Transplant 30: 888–895